About Protalex (OTCMKTS:PRTX)
Protalex, Inc. is a clinical-stage company. The Company is focused on the development of a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, including rheumatoid arthritis (RA) and Immune Thrombocytopenia (ITP). The Company's lead product candidate, PRTX-100, is a formulation of the Staphylococcal bacterial protein known as Protein A, which modifies aspects of the human immune system. PRTX-100 has the ability, at very low concentrations, to bind to human B-lymphocytes and macrophages and to modulate immune processes. The Company's pre-clinical studies demonstrated that low doses of PRTX-100 have potent therapeutic effects in certain models of immune-mediated inflammatory diseases. Both the PRTX-100-103 and the PRTX-100-104 studies demonstrated that PRTX-100 is safe and well tolerated at all dose levels.
Industry, Sector and Symbol
Industry Drug Manufacturers - Other
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Book Value($0.76) per share
Price / Book-0.71
Return on EquityN/A
Return on Assets-815.60%
Protalex (OTCMKTS:PRTX) Frequently Asked Questions
What is Protalex's stock symbol?
Protalex trades on the OTCMKTS under the ticker symbol "PRTX."
How were Protalex's earnings last quarter?
Protalex Inc. (OTCMKTS:PRTX) posted its quarterly earnings results on Wednesday, October, 11th. The company reported ($0.04) EPS for the quarter. View Protalex's Earnings History.
Who are some of Protalex's key competitors?
Some companies that are related to Protalex include Tonix Pharmaceuticals (TNXP), Neuralstem (CUR), AIT Therapeutics (AITB), Novus Therapeutics (NVUS), RegeneRx Biopharmaceuticals (RGRX), Anthera Pharmaceuticals (ANTH), Neovasc Inc (US) (NVCN), IntelliPharmaCeutics Intl (IPCI), Valeritas (VLRX), Dynatronics (DYNT), Sonoma Pharmaceuticals (SNOA), Onconova Therapeutics (ONTX), ContraVir Pharmaceuticals (CTRV), Bio-Path (BPTH), Soligenix (SNGX), Invivo Therapeutics (NVIV), Xenetic Biosciences (XBIO) and Fibrocell Science (FCSC).
Who are Protalex's key executives?
Protalex's management team includes the folowing people:
- Arnold P. Kling, President, Director (Age 57)
- Kirk M. Warshaw, Chief Financial Officer, Secretary, Director (Age 57)
- Marco M. Elser, Independent Director (Age 58)
How do I buy Protalex stock?
Shares of Protalex can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Protalex's stock price today?
One share of Protalex stock can currently be purchased for approximately $0.54.
How big of a company is Protalex?
Protalex has a market capitalization of $12.95 million. Protalex employs 2 workers across the globe.
How can I contact Protalex?
Protalex's mailing address is 131 COLUMBIA TURNPIKE SUITE 1, FLORHAM PARK NJ, 07932. The company can be reached via phone at 215-862-9720 or via email at [email protected]
MarketBeat Community Rating for Protalex (PRTX)MarketBeat's community ratings are surveys of what our community members think about Protalex and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Protalex (OTCMKTS:PRTX) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Protalex (OTCMKTS:PRTX) Earnings History and Estimates Chart
Protalex (OTCMKTS PRTX) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Protalex (OTCMKTS:PRTX) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Protalex (OTCMKTS:PRTX)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Protalex (OTCMKTS PRTX)
No insider trades for this company have been tracked by MarketBeat.com
Protalex (OTCMKTS PRTX) News Headlines
Protalex (OTCMKTS:PRTX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Protalex (OTCMKTS:PRTX) Income Statement, Balance Sheet and Cash Flow Statement
Protalex (OTCMKTS PRTX) Stock Chart for Sunday, February, 18, 2018